GLP‑1 prices without insurance: the open price index

GLP-1 cash prices as open indexes: program medians and quartiles, maker self-pay and list prices by dose, sources and check dates. A free CSV for each index.

What GLP-1 medication costs without insurance, as indexes: what the programs in our register charge, all in, and every maker self-pay price, each with its source, check date and CSV.

Maker prices checked . Program prices checked . Licensed CC BY 4.0.

The indexes

Explore an index

Compounded semaglutide program index

The 32 programs in our register that sell compounded semaglutide, which is not FDA-approved, with the medication included charge a median of $154 a month all in, from $49 to $299, and the middle half charge $96.44 to $199 (prices checked October 26, 2026).

Programs
32
Lowest
$49
25th pct.
$96.44
Median
$154
75th pct.
$199
Highest
$299
Mean
$155.28
WellMedr: $49 a monthEmbody: $69 a monthCollective: $75.58 a monthCoreAge Rx: $79 a monthLttl: $89 a monthYourEra: $89 a monthEnhanced: $89 a monthFMmeds: $95 a monthHealthRX: $96.92 a monthBrightmeds: $99 a monthGobyMeds: $99.67 a monthReadyRx: $109 a monthBelle: $109 a monthOak Longevity: $119 a monthLive Vital: $130.01 a monthZevay: $149 a monthbmiMD: $159 a monthMyDrHank: $171 a monthTrimRx: $174.83 a monthCoivas: $178 a monthRxSpan MD: $179 a monthGala Health: $179 a monthBodybuilding.com Health+: $179 a monthShedRx: $199 a monthHume Care: $199 a monthLuvo Health: $209 a monthDudeMeds: $213.06 a monthWellorithm: $247 a monthEnhance MD: $249 a monthFound: $289 a monthWillow: $299 a monthMEDGm: $299 a month$0$50$100$150$200$250$300
Each dot is one program’s all-in price a month. The shaded box spans the 25th to the 75th percentile; the dark rule is the median.
$299$49
Week ending Aug 16Nov 1
Weekly median, with the band from the lowest to the highest price.
#ProgramFormBillingPlanMembershipAll inChecked
1WellMedrInjectionYearly$49—$492026-10-26
2EmbodyInjectionYearly$69—$692026-10-26
3CollectiveInjectionMonthly$59$16.58$75.582026-10-26
4CoreAge RxInjectionYearly$79—$792026-10-26
5LttlInjectionYearly$89—$892026-10-26
6YourEraInjectionMonthly$89—$892026-10-26
7EnhancedInjectionYearly$89—$892026-10-26
8FMmedsInjectionYearly$95—$952026-10-26
9HealthRXInjectionYearly$96.92—$96.922026-10-26
10BrightmedsInjectionEvery 3 months$99—$992026-10-26
11GobyMedsInjectionOne payment$99.67—$99.672026-10-26
12ReadyRxInjectionEvery 3 months$109—$1092026-10-26
13BelleInjectionYearly$109—$1092026-10-26
14Oak LongevityInjectionYearly$119—$1192026-10-26
15Live VitalInjectionOne payment$130.01—$130.012026-10-20
16ZevayInjectionYearly$149—$1492026-10-26
17bmiMDInjectionMonthly$159—$1592026-10-26
18MyDrHankTabletsMonthly$171—$1712026-10-26
19TrimRxInjectionYearly$174.83—$174.832026-10-26
20CoivasInjectionEvery 3 months$178—$1782026-10-26
21RxSpan MDTabletsMonthly$179—$1792026-10-26
22Gala HealthInjectionMonthly$179—$1792026-10-26
23Bodybuilding.com Health+InjectionMonthly$179—$1792026-10-26
24ShedRxInjectionMonthly$199—$1992026-10-26
25Hume CareInjectionMonthly$199—$1992026-10-26
26Luvo HealthInjectionMonthly$209$104.50 first month—$2092026-10-26
27DudeMedsInjectionOne payment$213.06—$213.062026-10-22
28WellorithmTabletsMonthly$247$147 first month—$2472026-10-18
29Enhance MDInjectionMonthly$249$199 first month—$2492026-10-26
30FoundInjectionMonthly$289—$2892026-10-10
31WillowInjectionMonthly$299—$2992026-10-26
32MEDGmInjectionMonthly$299$179 first month—$2992026-10-26

The all-in monthly price of each program in our register that sells compounded semaglutide with the medication included: the plan plus any membership billed on top, one program per company. Plans billed for several months count at their monthly rate. How the statistics are computed. Compounded GLP-1s are not FDA-approved and are not the same products as the brand-name drugs: the FDA doesn’t review their safety, effectiveness or quality before they’re sold.

Interested in compounded semaglutide? See the best place to get it

WellMedr homepage
This program is for you
WellMedr
9.2/10Excellent
  • No FDA warning letter
  • Names its pharmacy
  • LegitScript certified
  • Prices checked Oct 26, 2026
$49 a month
12-month plan, $588 up front · $99 month to month
Doctor visit and medication included
Visit WellMedr

Data and method

How to cite

glp1.health. Open GLP-1 Price Index [data set]. Data as of October 26, 2026. https://www.glp1.health/tools/price-index. Licensed CC BY 4.0.

Reuse it under CC BY 4.0 with credit to glp1.health and the as-of date.

Method

List price (WAC)
Wholesale acquisition cost: the price the maker publishes to wholesalers, per package, before discounts and rebates. It is not what a patient pays.
Cash price
What a person with no insurance pays for one fill through the maker’s own pharmacy, as the maker states it, by dose. A year is the standing price times the fills in a year: 13 four-week fills or 12 thirty-day fills.
Program index
The all-in monthly price (the plan, the medication and any membership) of each program in our program register that sells one drug with the medication included, one program per company. Compounded drugs are not FDA-approved: the FDA doesn’t review their safety, effectiveness or quality before they’re sold.
Maker self-pay index
Every price a maker charges a patient who pays without insurance through its own pharmacy, per fill, by dose; the statistics count the standing prices, not first-fill offers or late-refill prices.
Statistics
A program index needs at least 3 programs. Quartiles and the median use linear interpolation between ranked prices (Hyndman and Fan type 7, as in R, NumPy and spreadsheet PERCENTILE.INC): the median of an even count is the mean of the two middle prices. Every statistic is rounded to the cent. The mean is the plain average. The weekly history records each index as it stood at the end of each week, on the Sunday that ends it.
Sources
The makers’ own pages: Novo Nordisk for Wegovy (list price), Ozempic (list price) and Rybelsus; Lilly for Zepbound (list price), Mounjaro (list price) and Foundayo (list price). Program prices come from the register, and each program links to its review, where its plans and check dates are listed.
Inclusion
Every brand-name product the makers sell in the United States (Wegovy, Zepbound, Ozempic, Mounjaro, Foundayo and Rybelsus), and every program in our register with a verified all-in monthly price, medication included. A program index needs at least 3 programs. A price goes in only when we can read it on a public page; we do not estimate a missing price.
Cadence
Every week we re-read each maker price from the page it cites. When the page still shows the same price, the check date moves; when it shows a new one, a person checks it before the row changes, and the change goes in the log. Program prices update with the register, and each program index is recorded at the end of every week. On the first day of each month the full index is frozen as a dated edition that never changes. The newest maker check was October 26, 2026 and the oldest still in the index October 25, 2026; the newest program check was October 26, 2026.
Limitations
Many prices are tiered by dose; program indexes use each program’s cheapest plan, which is often the starting dose or a plan billed for several months. Prices exclude insurance copays, net prices after rebates and Medicare or Medicaid prices: for those, use the cost calculator. The index does not include NADAC yet. Every figure is true on its check date only.
Questions

Questions about GLP‑1 prices

Wegovy costs $149 to $399 a month without insurance through NovoCare Pharmacy, depending on dose and form: $349 to $399 for the weekly pen and $149 to $299 for the daily tablets (prices checked October 25, 2026).

Zepbound costs $299 to $449 a month without insurance through LillyDirect for the weekly single-dose vials or KwikPen, depending on dose (prices checked October 26, 2026).

Ozempic costs $149 to $499 a month without insurance through NovoCare Pharmacy, depending on dose and form: $349 to $499 for the weekly pen and $149 to $299 for the daily pill (prices checked October 25, 2026).

Mounjaro costs $499 a month without insurance through LillyDirect for the weekly pen at every dose (prices checked October 26, 2026).

Foundayo costs $149 to $299 a month without insurance through LillyDirect for the daily tablets, depending on dose (prices checked October 26, 2026).

Rybelsus has no cash price without insurance: Novo Nordisk is replacing it with the Ozempic pill, which costs $149 to $299 a month through NovoCare Pharmacy (prices checked October 25, 2026).

Compounded semaglutide, which is not FDA-approved, costs $49 to $299 a month all in across the 32 programs we verified, with a median of $154 (prices checked October 26, 2026).

Compounded tirzepatide, which is not FDA-approved, costs $85.58 to $399 a month all in across the 32 programs we verified, with a median of $186 (prices checked October 26, 2026).

The 32 programs in our register that sell compounded semaglutide, which is not FDA-approved, with the medication included charge a median of $154 a month all in, from $49 to $299, and the middle half charge $96.44 to $199 (prices checked October 26, 2026).

The 32 programs in our register that sell compounded tirzepatide, which is not FDA-approved, with the medication included charge a median of $186 a month all in, from $85.58 to $399, and the middle half charge $137.50 to $254.64 (prices checked October 26, 2026).

The 3 programs in our register that sell Wegovy with the medication included charge a median of $1,349 a month all in, from $999 to $1,695, and the middle half charge $1,174 to $1,522 (prices checked October 26, 2026).

The 6 programs in our register that sell Zepbound with the medication included charge a median of $1,392 a month all in, from $1,069 to $1,599, and the middle half charge $1,320.50 to $1,399 (prices checked October 26, 2026).

The 5 programs in our register that sell Ozempic with the medication included charge a median of $1,299 a month all in, from $1,289 to $1,399, and the middle half charge $1,299 (prices checked October 26, 2026).

The 6 programs in our register that sell compounded semaglutide tablets, which are not FDA-approved, with the medication included charge a median of $253 a month all in, from $171 to $369, and the middle half charge $196 to $289 (prices checked October 26, 2026).

The 3 programs in our register that sell compounded tirzepatide tablets, which are not FDA-approved, with the medication included charge a median of $349 a month all in, from $199 to $399, and the middle half charge $274 to $374 (prices checked October 26, 2026).

The list price (WAC) is the maker's price to wholesalers before the confidential rebates insurers negotiate, so it is not what a patient pays. A maker's own self-pay program skips the wholesaler: the Wegovy pen at 0.25–2.4 mg costs $349 a fill bought direct, 74% below its $1,349.02 list price. Judge affordability by the cash price, not the list price.

Wholesale acquisition cost: the maker’s published price to wholesalers, before any discounts or rebates. It is not what pharmacies pay (that is closer to NADAC), not what insurers pay net of rebates, and not what cash programs charge.

Every week we re-read each maker price from the maker’s own self-pay or list-price page. Program prices come from the same verified prices that rank our /best pages, and each one links to the review of its program. Every row stores its source and its check date, and on the first day of each month the full index is frozen as a dated edition.

Yes: every file is licensed CC BY 4.0. Use it in articles, dashboards or research with credit to glp1.health and the as-of date. Each index has its own CSV.
The data behind this tool